Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia
· Delayed Price · Currency is AUD 4.550
-0.420 (-8.45%)
Dec 20, 2024, 4:10 PM AEST
Clarity Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M AUD with 17.41% growth. Clarity Pharmaceuticals had revenue of 6.09M in the half year ending June 30, 2024, with 66.73% growth.
Revenue
11.51M
Revenue Growth
+17.41%
P/S Ratio
108.01
Revenue / Employee
230.13K
Employees
50
Market Cap
1.46B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.74B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Telix Pharmaceuticals Limited | 645.68M |
| Ramsay Health Care Limited | 16.66B |
Clarity Pharmaceuticals News
- 18 days ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
- 19 days ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
- 2 months ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
- 5 months ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review